Exhibit 32.2
CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
I, Robert J. Davis, the Chief Financial Officer of Liberator Medical Holdings, Inc., certify,
pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of
2002, that:
| |
(1) |
|
This quarterly report on Form 10-Q of
the Company for the quarter ended
December 31, 2009 (the Report) fully
complies with the requirements of
Section 13(a) or 15(d) of the
Securities Exchange Act of 1934 (15
U.S.C. 78m or 78o(d)); and |
| |
| |
(2) |
|
The information contained in this Form
10-Q fairly presents, in all material
respects, the financial condition and
results of operations of the Company. |
| |
|
|
|
|
| |
|
|
| Dated: February 11, 2010 |
|
/s/ Robert J. Davis
|
|
| |
|
Robert J. Davis |
|
| |
|
Chief Financial Officer |
|
| |